2Matsushima T,Murakami H,Tsuchiya J.Myelodysplastic syndrome with marrow eosinophilia:clinical and cytogenetic features.Leuk Lymphoma,1994,15:491-497. 被引量：1
3Passmore SJ,Hann IM,Stiller CA,et al.Pediatric myelodysplastic:a study of 68 children and a new prognostic scoring system.Blood,1995,85:1742-1750. 被引量：1
4Sasaki H,Manabe A,Kojima S,et al .Myelodysplastic syndrome in childhood:a retrospective study of 189 patients in Japan.Leukemia,2001,15:1713-1720. 被引量：1
5Wimazal F,Sperr WR,Kundi M,et al.Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.Leuk Res,2001,25:287-294. 被引量：1
5Steensma DP,Bennett JM.The Myelodysplastic syndromes:Diagnosis and treatment[J].Mayo Clin Proc,2006,81(1):104-130. 被引量：1
6Ohara A,Kojima S,Manabe A,et al.Epidemiology of childhood AA and MDS in Japan[J].Leukemia Res,2006,30(suppl 2):S11-S12. 被引量：1
7Steensma DP,Tefferi A.The Myelodysplastic syndromes:A perspective and review highlighting current controversies[J].Leuk Res,2003,27(2):95-120. 被引量：1
8Steensma DP,List AF.Genetic testing in the myelodysplastic syndromes:Molecular insights into hematologic diversity[J].Mayol Clin Proc,2005,80(5):681-698. 被引量：1
9Howe RB,Porwit-MacDonald A,Wanat R,et al.The WHO classification of the MDS does make a difference[J].Blood,2004,103(9):3265-3270. 被引量：1
10Shimamoto T,Tohyama K,Okamoto T,et al.Cyclosporin A therapy for patients with myelodysplastic syndrome:Multicenter pilot studies in Japan[J].Leukemia Res,2003,27(9):783-788. 被引量：1
